undefined

Francisco Gonzalez-Lima

Professor of Neuroscience and Pharmacology & Toxicology

Top 3 podcasts with Francisco Gonzalez-Lima

Ranked by the Snipd community
undefined
11 snips
Apr 17, 2022 • 1h 42min

Health Benefits of Methylene Blue - Discussion Between Francisco Gonzalez-Lima, Ph.D. & Dr. Mercola

In this interview, Francisco Gonzalez-Lima, Ph.D., discusses a really powerful strategy to improve your mitochondria, which generate the vast majority of the energy your cells produce from food.
undefined
May 26, 2020 • 59min

Episode 107: Francisco Gonzalez-Lima discusses methylene blue and near-infrared light as therapies for cognitive disorders

Behavioral neuroscientist Dr. Francisco Gonzalez-Lima discusses the use of low-dose methylene blue and near-infrared light as therapies for cognitive disorders. Topics include mitochondrial respiration, cognitive benefits of interventions, historical origins of methylene blue, strategies for synergy, and conversations on neurodegeneration and cognitive enhancement.
undefined
Jan 28, 2019 • 2h 32min

#38 - Francisco Gonzalez-Lima, Ph.D.: Advancing Alzheimer’s disease treatment and prevention – is AD actually a vascular and metabolic disease?

In this episode, Francisco Gonzalez-Lima, a Professor of Neuroscience and Pharmacology & Toxicology, explains the vascular hypothesis of Alzheimer’s disease which says the central problem is a progressive neuronal energy crisis of impaired blood flow to the brain and impaired mitochondrial respiration. He walks us through the ways we can intervene in this process and also shares details of the exciting future of Alzheimer’s treatment and prevention. We discuss: Background and interest in the brain [5:15]; The unique nature of the human brain [9:15]; Why we’ve made so little progress in Alzheimer’s research [23:00]; The amyloid beta hypothesis [28:30]; Hypometabolism in the brain leading to cognitive decline [39:30]; Early signs of AD, and deciphering between age-related decline versus something pathologic [47:45]; The vascular hypothesis of Alzheimer’s disease [54:00]; The relationship between mitochondria, cytochrome c oxidase, and Alzheimer’s disease [1:08:00]; Chronic inhibition of cytochrome c oxidase leads to chronic neurodegenerative disease [1:22:45]; Major risk factors for AD, head trauma, and other forms of dementia [1:33:45]; Methylene blue for treating and preventing neurodegeneration [1:38:15]; Current standard of care for AD, and the reasons for a lack of advancement [2:01:45]; Near infrared light as a targeted treatment for cognitive decline [2:05:30]; The ketogenic diet as a treatment and preventative measure [2:13:15]; Exciting future research coming from Francisco [2:23:00]; Methylene blue for traumatic brain injuries [2:25:15]; and More. Learn more at www.PeterAttiaMD.com Connect with Peter on Facebook | Twitter | Instagram.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app